Literature DB >> 19027885

Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation.

Jayanarayan Kulathingal1, Li-Wen Ko, Bernadette Cusack, Shu-Hui Yen.   

Abstract

A tetracycline inducible transfectant cell line (3D5) capable of producing soluble and sarkosyl-insoluble assemblies of wild-type human alpha-synuclein (alpha-Syn) upon differentiation with retinoic acid was used to study the impact of alpha-Syn accumulation on protein phosphorylation and glycosylation. Soluble proteins from 3D5 cells, with or without the induced alpha-Syn expression were analyzed by two-dimensional gel electrophoresis and staining of gels with dyes that bind to proteins (Sypro ruby), phosphoproteins (Pro-Q diamond) and glycoproteins (Pro-Q emerald). Phosphoproteins were further confirmed by binding to immobilized metal ion affinity column. alpha-Syn accumulation caused differential phosphorylation and glycosylation of 16 and 12, proteins, respectively, whose identity was revealed by mass spectrometry. These proteins, including HSP90, have diverse biological functions including protein folding, signal transduction, protein degradation and cytoskeletal regulation. Importantly, cells accumulating alpha-Syn assemblies with different abilities to bind thioflavin S displayed different changes in phosphorylation and glycosylation. Consistent with the cell-based studies, we demonstrated a reduced level of phosphorylated HSP90 alpha/beta in the substantia nigra of subjects with Parkinson's disease as compared to normal controls. Together, the results indicate that alpha-Syn accumulation causes complex cellular responses, which if persist may compromise cell viability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027885      PMCID: PMC2679264          DOI: 10.1016/j.bbapap.2008.09.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

Review 1.  O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate.

Authors:  F I Comer; G W Hart
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

2.  Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.

Authors:  F Liu; T Zaidi; K Iqbal; I Grundke-Iqbal; C-X Gong
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 3.  Specificity of 14-3-3 isoform dimer interactions and phosphorylation.

Authors:  A Aitken; H Baxter; T Dubois; S Clokie; S Mackie; K Mitchell; A Peden; E Zemlickova
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

4.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

5.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

6.  Glycosylation of transferrin in Alzheimer's disease and alcohol-induced dementia.

Authors:  S J van Rensburg; P A Berman; F C Potocnik; J J Taljaard
Journal:  Metab Brain Dis       Date:  2000-12       Impact factor: 3.584

7.  The level and phosphorylation of Hsp70 in the rat liver cytosol after adrenalectomy and hyperthermia.

Authors:  A Cvoro; J Dundjerski; D Trajković; G Matić
Journal:  Cell Biol Int       Date:  1999       Impact factor: 3.612

8.  14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.

Authors:  Yasuhiro Kawamoto; Ichiro Akiguchi; Shinichi Nakamura; Yasuyuki Honjyo; Hiroshi Shibasaki; Herbert Budka
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

9.  Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells.

Authors:  Li-Wen Ko; Hwai-Hwa C Ko; Wen-Lang Lin; Jayanranyan G Kulathingal; Shu-Hui C Yen
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

10.  Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.

Authors:  Hong-Tao Li; Hai-Ning Du; Lin Tang; Jun Hu; Hong-Yu Hu
Journal:  Biopolymers       Date:  2002-08-05       Impact factor: 2.505

View more
  3 in total

Review 1.  Heat shock proteins: cellular and molecular mechanisms in the central nervous system.

Authors:  R Anne Stetler; Yu Gan; Wenting Zhang; Anthony K Liou; Yanqin Gao; Guodong Cao; Jun Chen
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

2.  Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.

Authors:  Sunny Rae Slone; Nicholas Lavalley; Michael McFerrin; Bing Wang; Talene Alene Yacoubian
Journal:  Neurobiol Dis       Date:  2015-04-08       Impact factor: 5.996

3.  Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons.

Authors:  Peizhou Jiang; Ming Gan; Shu-Hui Yen; Simon Moussaud; Pamela J McLean; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2016-02-02       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.